1-800-PublicRelations "1800pr"

Monthly Archives: February 2016

16 Feb

CEO Kevin Lasser of JEMS Technology to Be Interviewed Live on Clear Channel’s “The Trader’s Network Show”

Live Interview to Air March 7th 2015 Hosted by Michael Yorba, 2:30pm ET/11:30am PT/1:30pm CT

ORION, MI – (Mar 6, 2015) – JEMS Technology, a telehealth solutions company that improves security, immediacy, quality, and mobility, announced today that Chief Executive Officer (CEO) Kevin Lasser will be featured live on Saturday, March 7, 2015 at 2:30pm ET by host Michael Yorba on Clear Channel – iHeart Business Talk Radio’s “The Trader’s Network Show.” In this exclusive interview, Kevin Lasser will discuss how Healthcare providers have suffered without a reliable telemedicine system for secure real-time mobile until “The JEMS™ Mobile Health System.” The system is available everywhere, including over 3G, 4G, and “coffee shop” Wi-Fi. He will also discuss how JEMS Technology is now being utilized in non-healthcare markets.

We encourage all shareholders, analysts, industry professionals and interested parties to tune in live. The details and link to iHeart Radio’s live worldwide stream are below.

Date: March 7, 2015
Start Time: 2:30pm ET | 11:30am PT | 1:30pm CT
Network: Clear Channel / iHeart Radio
Station: DFW 1190AM KFXR
KFXR Show: The Trader’s Network Show
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more information visit its website at www.clearchannel.com.

About The Trader’s Network Show
For the past six years “The Trader’s Network Show” has been hosted and broadcasted live daily on Clear Channel DFW 1190AM KFXR from 7am – 8am, Monday-Friday and Saturdays from 1pm – 3pm ET. Host Michael Yorba interviews the front-page titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and investment insights in a new light and keeps audiences asking for more… Shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s The Trader’s Network Show.

About Kevin Lasser
Mr. Kevin Lasser has 29 years of experience in business building, finance, and technology solutions. Mr. Lasser is Chief Executive of JEMS Technology — the mobile health care solution that provides a consult anytime, anywhere. He oversees global business operations for JEMS — which is becoming the preferred telehealth choice for health care providers in North America, and Asia in both private and public institutions. Additionally, he is a committee member of the inaugural mobile health HIMSS (Healthcare Information and Management Systems Society) committee and past chair of MTAM’s (Mobile Technology Association of Michigan) mHealth Advisory Council.

Prior to JEMS, Mr. Lasser was Chief Executive Officer and co-founder of Encryption Security Solutions (ESS) and Pure Entropy Technologies (PET) where he led both companies in becoming best in class providers of encryption/cyber security solutions to private (through ESS) and public (through PET) institutions.

Prior to ESS and PET, Mr. Lasser was President and founder of Sage Financial Corporation (Sage). Sage was consistently honored with “Top Ten Money Finders Group Awards” from esteemed financial organizations such as GE Capital, Pitney Bowes Financial and Maryland National Financial Corp. Sage funded approximately $220 million for small to mid-size businesses over a ten year period.

Mr. Lasser is a well sought after key thought leader on matters of telehealth. He has spoken on many topics including “The ROI in Health Care on Mobile Devices,” “Bio Medical Wireless Technologies,” “Health Care Technology for Critical Access Facilities,” “The Impact of Mobile Devices in Healthcare,” and the recipient of numerous professional awards.

About JEMS Technology
Headquartered in Orion, Mich., JEMS Technology’s focus is simple: Consult. Anytime. Anywhere. It specializes in secure, encrypted (HIPAA compliant) real-time video to hand held devices, including the iPhone, iPad, Android-based phones and Android-based tablets. JEMS Technology is focused on the healthcare market, where remote access to secure live video can assist healthcare providers to deliver better care. From real-time video to phone connectivity, JEMS Technology is effective, easy-to-use and easy to implement.

The JEMS platform is adaptable and scalable — the JEMS suite of solutions is being utilized in various health care disciplines (tele-neurology, tele-ALS, tele-OR, tele-OB, tele-cardiology, etc). in both private and public institutions (DHS, VA, Department of Justice). JEMS is also delivering immediate best in class health care for better outcomes from places other than health care facilities (first responder vehicles, residences, etc).

Additionally, JEMS is now being utilized in non-healthcare markets. One such example is “tele-engineering.” Rather than travel to various manufacturing plants to repair equipment, an engineer can advise others on how to make those repairs in an immediate, efficient and secure manner from the convenience of their smart device.

For more information on JEMS Technology, visit http://www.JEMSTech.com.

A 1800PublicRelations.com PR Event…

Contact
Interview Press / Media Contact
Matthew Bird
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Traders Network Show Comments Off on CEO Kevin Lasser of JEMS Technology to Be Interviewed Live on Clear Channel’s “The Trader’s Network Show” Read more...
16 Feb

WindStream Technologies, Inc. CEO Daniel Bates to Be Interviewed on Clear Channel – iHeart Business Talk Radio’s “The Trader’s Network” on December 5, 2014

Live Interview Airs on The Trader’s Network Radio Show, Hosted by Michael Yorba, 9:30pm ET/6:30pm PT/8:30pm CT

NORTH VERNON, IN — 12/05/14 — WindStream Technologies, Inc. (OTCBB: WSTI), the Company that has developed and tested the first-of-its-kind, integrated, hybrid energy solution and is now marketing and selling SolarMills® to a worldwide customer base, announced today that CEO Daniel Bates will be interviewed live by host Michael Yorba on Clear Channel – iHeart Business Talk Radio’s The Traders Network Show. In this exclusive 2-segment interview, Mr. Bates will discuss how the company is engaged in the development and commercialization of wind driven electrical generation products in the United States and internationally. We encourage investors, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: December 5, 2014
Start Time: 9:30pm ET | 6:30pm PT | 8:30pm CT (U.S.)
Network: Clear Channel – iHeart
Station: DFW 1190AM
KFXR Show: The Trader’s Network
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About WindStream Technologies, Inc.: WindStream Technologies, Inc. was established in 2008 with the goal of designing, prototyping and manufacturing affordable and scalable renewable energy technologies for a global marketplace. The Company has developed and tested the first-of-its-kind, integrated, hybrid energy solution and is now marketing and selling SolarMills® to a worldwide customer base.

In 2009, the Company set up its Research and Development facilities at the Purdue Research Center in New Albany, Indiana with an academic alliance with Purdue University and a generous grant from the State of Indiana. Engineers were hired for their expertise in fluid dynamics, turbine design, power electronics and electro mechanical engineering. The Company set out to build a system that was unique in the industry focusing on a highly efficient design that was able to leverage manufacturing techniques commonly found in mass-production environments.

Upon completing many rounds of prototyping and testing, both in the lab and in real world environments, WindStream set up its manufacturing facilities in 2011 in a 50,000 sq. ft. facility in North Vernon, Indiana where it currently manufactures and ships its products to customers all over the world.

The Company has recently set up its India/South Asia Operations under the name of WindStream Energy Technologies, Private Limited with the intent of servicing that part of the world with products manufactured in India under the close inspection of WindStream USA. WindStream will continue to manufacture and ship its products globally from its Indiana facilities.

The Company has been granted U.S. patents for its technology with a suite of additional patents both domestic and international in various stages of prosecution.

About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.

About The Traders Network Show: For the past six years “The Traders Network Show” has been hosted and broadcasted live daily on Clear Channel DFW 1190AM KFXR from 6am – 7:30am and 2pm – 3pm CT, Monday-Friday. Host Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s The Traders Network Show. To inquire about being a guest on this show please contact “1800pr” at www.1800PublicRelations.com.

Company Contact:
WindStream Technologies, Inc.
819 Buckeye Street
North Vernon, IN 47265
+1 (812) 953-1481
http://www.windstream-inc.com

Interview Press / Media Contact:
Matthew Bird
President
1-800-PublicRelations
917.409.8211
Matt.Bird@1800pr.com
www.1800pr.com

By Traders Network Show Comments Off on WindStream Technologies, Inc. CEO Daniel Bates to Be Interviewed on Clear Channel – iHeart Business Talk Radio’s “The Trader’s Network” on December 5, 2014 Read more...
16 Feb

President & CEO Leen Kawas, PhD of M3 Biotechnology, Inc. to Be Interviewed Live on Clear Channel’s “The Trader’s Network Show”

Live Interview to Air March 14th 2015 hosted by Michael Yorba, 1:30pm ET/10:30am PT/12:30pm CT

SEATTLE, WA–(Mar 13, 2015) – Leen Kawas, Ph.D, CEO of an innovative young therapeutics company named M3 Biotechnology, Inc., that has a novel platform of drugs which could reverse the course of neurodegenerative diseases like Parkinson’s Disease and Alzheimer’s by inducing brain cells to grow again, will be interviewed on a Clear Channel iHeart Business Radio’s live worldwide stream.

Kawas will be interviewed live on Saturday, March 14, 2015, at 1:30 p.m. ET by host Michael Yorba on “The Trader’s Network,” to discuss M3’s growth-factor-modifying pharmaceuticals platform that has begun to attract significant interest having completed animal trials and now moving toward human trials.

We encourage all shareholders, analysts, industry professionals and interested parties to tune in live. The details and link to iHeart Radio’s live worldwide steam are below.

Date: March 14, 2015
Start Time: 1:30pm ET | 10:30am PT | 12:30pm CT
Network: Clear Channel/ iHeart Radio
Station: DFW 1190AM KFXR
KFXR Show: The Traders Network Show
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more information visit its website at www.clearchannel.com.

About The Traders Network Show
For the past six years “The Traders Network Show” has been hosted and broadcasted live daily on Clear Channel DFW 1190AM KFXR from 7am – 8am, Monday-Friday and Saturdays from 1pm – 3pm ET. Host Michael Yorba interviews the front-page titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and investment insights in a new light and keeps audiences asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s The Traders Network Show.

About President and CEO Leen Kawas, PhD.
The young firm where Kawas became CEO on late 2013 has developed a drug, now moving toward initial human trials, a drug that would not merely slow but actually reverse the course of neurodegenerative diseases like Parkinson’s Disease and Alzheimer’s. Dr. Kawas was co-inventor of the drug and co-founder of M3.

In addition to co-inventing the drug MM-201 and guiding the company toward its funding goals, M3’s scientist has successfully obtained grant-funding from noteworthy national organizations like the National Institutes of Health, the Alzheimer’s Drug Discovery Fund and the Michael J. Fox Foundation and impressive grant support from the Life Science Discovery Fund in Washington State.

M3’s drug is not merely a novel technology to addressing the neurodegenerative diseases but the approach for which she plans to seek FDA approval is also novel, taking advantage of a fast-track designation the FDA has approved to dramatically reduce the time and data required to enhance efficiency in getting drugs to market.

Kawas unique combination of scientific and medical knowledge, starting her career as a clinical pharmacist and then getting her PhD in molecular Pharmacology, give her the credibility to lead the company in its next research-intensive phase. While growing the company’s science and licensing the technology out of Washington State University, Kawas was also able to raise more than $2 million from both dilutive and non-dilutive sources, including grants from the National Institute of Health (NIH), Alzheimer’s Drug Discovery and Michael J Fox Foundations, to support development of the therapeutics being advanced in M3, especially MM-201. Dr. Kawas’ goal and passion is entrepreneurship that leads to disease modifying pharmaceuticals that address critical unmet medical needs. And as a female entrepreneur with a scientific background, Kawas is committed to mentoring women in science and business and has been selected for programs to inspire women to go into those fields, and was featured as a role model for women in a profile recently in a Spokane, WA business magazine. For Kawas, the challenge of raising investment capital for her start-up company while overcoming the array of obstacles facing a 29-year-old Middle Eastern female are more than offset by the successes she has been able to achieve.

About M3 Biotechnology, Inc.
M3 is preparing for a Phase I clinical trial of its patented small molecule therapy, MM-201. MM-201 is an orally delivered drug that causes stem cells to differentiate into neuron cells at a rate faster than degenerative brain diseases, such as Parkinson’s and Alzheimer’s, destroys them. During this trial, it is expected that M3 will enter into a license agreement with one of six large pharmaceutical companies to complete the FDA approval process and prepare for commercially manufacturing and marketing the drug. As a disease modifying and feasibly delivered drug, it is expected that MM201 will become the standard of care for patients afflicted with these diseases.

MM-201, with its first-in-class growth actor-activation process and unique small-molecule characteristic, which represents an important opportunity for potential investors as M3 raises the funds necessary to enable MM-201 to move through human trials and to market. The uniqueness of MM-201 is that it is orally available, able to permeate the protective blood brain barrier and thus modify the effects of Parkinson’s disease (PD) and Alzheimer’s disease (AD).

M3’s initial development work has been supported by grants from both the Michael J. Fox Foundation and the Alzheimer’s Drug Discovery Foundation, Life Science Discovery fund financial support stemming from the understanding of those foundations of the novel paradigm that M3’s technology represents. This support shows the understanding that M3’s technology could, for the first time in a non-invasive way as compared to Deep Brain Stimulation and other technologies in the pipeline, stop and possibly reverse the clinical course of these diseases. In addition to the life-altering potential of this drug, success would quickly lead to domination in a multi-billion dollar market.

The drug has demonstrated efficacy in numerous animal models of neurodegenerative disease (NDD) including the rat scopolamine dementia model, the aged rat dementia model and the Rat 6-OHDA model of PD.

A 1800PublicRelations.com PR Event…

CONTACT INFORMATION

 

By Traders Network Show Comments Off on President & CEO Leen Kawas, PhD of M3 Biotechnology, Inc. to Be Interviewed Live on Clear Channel’s “The Trader’s Network Show” Read more...
16 Feb

CEO & Founder Cort Smith of Da Vinci Vaporizer to Be Interviewed Live on iHeart Radio / Clear Channel Atlanta Studios – 640 WGST AM’s “Health Tech Talk Live”

Live Interview to Air on March 14th, 2015, Hosted by Ben Chodor, 3:00pm ET/12:00pm PT/2:00pm CT

LAS VEGAS, NV (Mar 13, 2015) – Da Vinci Vaporizer, a company that manufactures and retails advanced vaporizer products and accessories, announced today that Chief Executive Officer (CEO) and Founder Cort Smith will be interviewed live on iHeart Radio’s Health Tech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio / Clear Channel Atlanta Studios – 640 WGST AM tomorrow, at 3:00pm ET. In this exclusive interview, Mr. Smith will discuss the portability, reliability, function, innovation and service, all key factors, which contribute to each and every one of their products. We encourage all shareholders, analysts, industry professionals and interested parties to tune in live. The details and link to iHeart Radio’s live worldwide steam are below.

Date: March 14, 2015
Start Time: 3:30pm ET | 12:30pm PT | 2:30pm CT (U.S.)
Network: iHeart Radio/ Clear Channel
Station: 640 WGST AM
Show: Health Tech Talk Live
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE

About Da Vinci Vaporizer
Our mission is to bring innovative products from mind to market. Da Vinci Vaporizer is the most notorious of our brands that is held by East West Bridge, the mother ship. Alongside Da Vinci, we build products in the automobile accessory market, the human mobility market and the durable medical goods industry. Outside of our own brands, we build over 400 products for other US companies that utilize our presence in China. We have over 100 people in the organization in 3 cities globally.

About CEO and Founder Cort Smith
Cort Smith grew up in the Bay Area CA with a strong interest in technology and how things are put together. In 1988, Cort moved to Taiwan where he set up his first international business of Bungee Jumping. By 1995 he began building bungee towers all over China and quickly developed the language and skills needed to work with Chinese manufacturers. While in China Cort produced China’s first X games and worked alongside many multi-national companies. By 2002 Cort returned to the US and settled in Las Vegas where he continues to create new products and manage an “extremely” vibrant business.

About iHeart Radio/ Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About Health Tech Talk Live
Health Tech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm ET every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s Health Tech Talk Live. Visit iHeart Radio’s HealthTech Talk Radio Show or visit www.HealthTechTalk.com.

If you’re interested in being a guest on Health Tech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

A 1800PublicRelations.com PR Event…

By HealthTech Talk Comments Off on CEO & Founder Cort Smith of Da Vinci Vaporizer to Be Interviewed Live on iHeart Radio / Clear Channel Atlanta Studios – 640 WGST AM’s “Health Tech Talk Live” Read more...
16 Feb

CEO Nicholas U. Spring ReliefBand® Medical Technologies LLC to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM’s “Health Tech Talk Live”

Live Interview to Air on March 14th 2015, Hosted by Ben Chodor, 3:30pm ET/12:30pm PT/2:30pm CT

CHICAGO, IL (Mar 13, 2015) – ReliefBand® Medical Technologies LLC, a company passionately devoted to developing FDA cleared and clinically tested digital, wearable devices that stop both nausea and vomiting, announced today that member of the Board of Directors and Chief Executive Officer (CEO) Nicholas (Nick) U. Spring will be interviewed live on iHeart Radio’s Health Tech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM tomorrow, at 3:30pm ET. In this exclusive interview, Mr. Spring will discuss how the wearable devices are not only easy to use and generally work within minutes of application, but are comfortable and have simple to replace batteries. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: March 14, 2015
Start Time: 3:30pm ET | 12:30pm PT | 2:30pm CT (U.S.)
Network: iHeart Radio/ Clear Channel
Station: 640 WGST AM
Show: Health Tech Talk Live
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE 

About Reliefband® Medical Technologies LLC: ReliefBand Medical Technologies is a Neurotechnology (software and data) and marketing company that provides leading edge personalized medical treatments, which put patients in control of their treatment and their lives because our proprietary, FDA cleared, wearable waveform technology is non-invasive, highly effective and precisely controlled by the user. It can be turned off, on, up or down to suit individual needs.

About Director & CEO Nicholas (Nick) U. Spring: Nicholas (Nick) U. Spring is an experienced CEO, successful executive and entrepreneur with a track record of company startups, development and exits in the OTC and Rx Pharmaceutical markets. Topaz Pharmaceuticals Inc., the company that he founded in 2005, was acquired by Sanofi Pasteur in 2011. He personally led Topaz through multiple rounds of financing, R&D (pre-clinical to FDA submission) as CEO & President and Board Member. The FDA approved Sklice®, the product that he founded the company upon, on Feb 7, 2012 — a major achievement for a small startup company. Nick has worked closely with digital healthcare companies as well as middle to big Pharma companies advising them at the highest level on business strategies and life cycle management. Prior to that he enjoyed a global career at Merck as a senior manager in many countries worldwide. Nick is also a Business Adviser with the Science Center of Philadelphia’s QED program for innovation, an Adjunct Professor of Pharmaceutical and Healthcare business at the University of Sciences, Philadelphia and was recently elected to the Commercialization Advisory Board of Penn State College of Medicine.

About iHeart Radio/ Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About Health Tech Talk Live
Health Tech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s Health Tech Talk Live. Visit iHeart Radio’s HealthTech Talk Radio Show or visit www.HealthTechTalk.com.

If you’re interested in being a guest on Health Tech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

By HealthTech Talk Comments Off on CEO Nicholas U. Spring ReliefBand® Medical Technologies LLC to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM’s “Health Tech Talk Live” Read more...
16 Feb

CEO Tom Brophy of CUR Media, Inc. to Be Interviewed Live on Clear Channel’s “The Trader’s Network Show”

Live Interview to Air March 7th 2015 Hosted by Michael Yorba, 1:00pm ET/10:00am PT/12:00pm CT

GLASTONBURY, CT–(Mar 6, 2015) – CÜR Media, Inc. (OTCQB: CURM) (OTCBB: CURM) announced today that Founder and Chief Executive Officer (CEO) Tom Brophy will be interviewed live tomorrow by host Michael Yorba on Clear Channel — iHeart Business Talk Radio’s, “The Trader’s Network Show.”

In this exclusive double-segment interview, Mr. Brophy will discuss how CÜR Media is developing a next generation social music experience through the planned launch of CÜR Music, a social streaming music application and website that is being designed to enable its users to go beyond the limitations of traditional music streaming services. He will also discuss recent business developments that will shape the planned launch of CÜR Music later this year in the multi-billion dollar music industry.

All Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s iHeart Radio stream.

Date: March 7, 2015
Start Time: 1:00pm ET | 10:00am PT | 12:00pm CT (U.S.)
Network: Clear Channel — iHeart
Station: DFW 1190AM
KFXR Show: The Trader’s Network
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About CÜR Media
CÜR Media is creating a next generation social music experience through the planned launch of CÜR Music, a social streaming music application and website that is being designed to enable its users to go beyond the limitations of traditional music streaming services. CÜR Music will unlock the true expressive nature of an individual’s connection with their music by fostering personalization, sharing and creativity. With CÜR Music it’s not just about streaming, it’s about what the music means to you and how you want to express that to the world. For more information please visit www.curmusic.com.

About CEO Tom Brophy
Mr. Brophy has been involved in Executive roles of start-ups and growth companies since 1994. Mr. Brophy was the CFO of Interactive Search Holdings, the first company to mass distribute search toolbars across the web, pioneering the search toolbar business which became a multi-billion dollar industry. The Company was also the first company to mass distribute smiley emoticons as part of its toolbar distribution strategy. Mr. Brophy started his career at Deloitte & Touche, has been the Chief Financial Officer of several startup and growth companies and has several successful exits. He has also been the Chief Financial Officer of a public company.

About Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more information visit its website at www.clearchannel.com.

About The Traders Network Show
For the past six years “The Traders Network Show” has been hosted and broadcasted live daily on Clear Channel DFW 1190AM KFXR from 7am – 8am, Monday-Friday and Saturdays from 1pm – 3pm ET. Host Michael Yorba interviews the front-page titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and investment insights in a new light and keeps audiences asking for more. Shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s The Traders Network Show.

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the development of a commercially viable streaming music product, (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items, (iii) the Company’s future financial performance, (iv) the Company’s ability to negotiate economically feasible agreements with the major and independent music labels and publisher rights organizations, and (v) the assumptions underlying or relating to any statement described in points (i), (ii), (iii), (iv) and (v) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company’s current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the Company’s inability to obtain adequate financing, the length of time associated with development of mobile applications and related insufficient cash flows and resulting illiquidity, the Company’s inability to expand the Company’s business, lack of product diversification, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies.

A 1800PublicRelations.com PR Event.

CONTACT INFORMATION

By Traders Network Show Comments Off on CEO Tom Brophy of CUR Media, Inc. to Be Interviewed Live on Clear Channel’s “The Trader’s Network Show” Read more...
16 Feb

Chief Medical Officer & Co-Founder Katrina Firlik, MD of HealthPrize Technologies to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM’s “HealthTech Talk”

Live Interview to Air on March 28th 2015, Hosted by Ben Chodor, 3:30pm ET/12:30pm PT/2:30pm CT

NORWALK, CT (Mar 27, 2015) – HealthPrize Technologies, a digital health leader in patient engagement and medication adherence solutions, announced today that Chief Medical Officer and Co-Founder Katrina Firlik, MD will be interviewed live on iHeart Radio’s Health Tech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM tomorrow, at 3:30pm ET. In this exclusive interview, Dr. Firlik will discuss their customizable platform, which combines incentives, behavioral economics, gamification and education to motivate patients to take charge of their own health and wellness. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: March 28, 2015 

Start Time: 3:30pm ET | 12:30pm PT | 2:30pm CT (U.S.)

Network: iHeart Radio/ Clear Channel

Station: 640 WGST AM

Show: Health Tech Talk Live

Host: Ben Chodor

iHeart Radio Live Stream: CLICK HERE

About HealthPrize Technologies
HealthPrize’s Software-as-a-Service (SaaS) medication adherence and patient engagement platform provides an innovative approach to addressing the problem of medication non-adherence with an online and mobile-based program that is fun, educational and rewarding. The HealthPrize system leverages gaming dynamics, behavioral economics and proven concepts from consumer marketing to maximize engagement while also using education to strengthen the intrinsic motivation required for long-term persistence to prescribed medications. For more information, visit www.healthprize.com and follow us on Twitter at @HealthPrize.

About Chief Medical Officer and Co-Founder Katrina Firlik, MD
Prior to founding HealthPrize Technologies, Katrina was a neurosurgeon in private practice at Greenwich Hospital in Greenwich, Connecticut, and on the clinical faculty at Yale University School of Medicine. In addition to her scientific publications, Katrina is the author of Another Day in the Frontal Lobe: A Brain Surgeon Exposes Life on the Inside, published by Random House and reviewed by The New York Times, The Los Angeles Times, and O Magazine. She has appeared on CNN, Fox, and MSNBC as a commentator on a variety of medical issues. She is also an inventor of a brain stimulation device designed to enhance recovery after stroke. Katrina completed her undergraduate studies at Cornell University with a major in cultural anthropology. She attended medical school at Case Western Reserve University, and did her neurosurgery residency at the University of Pittsburgh, one of the largest neurosurgery centers in the country, where she was the first woman accepted to the program. Katrina also completed a specialty fellowship in epilepsy surgery at Yale University. She is a member of the HealthPrize Board of Directors.

About iHeart Radio/ Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About Health Tech Talk Live
Health Tech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s Health Tech Talk Live. Visit iHeart Radio’s HealthTech Talk Radio Show or visit www.HealthTechTalk.com.

If you’re interested in being a guest on Health Tech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

Interview Press/ Media
Matthew Bird
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By HealthTech Talk Comments Off on Chief Medical Officer & Co-Founder Katrina Firlik, MD of HealthPrize Technologies to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM’s “HealthTech Talk” Read more...
16 Feb

CEO Gregory D. Cash of BioSig Technologies, Inc. to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM’s “HealthTech Talk”

Live Interview to Air on April 4th 2015, Hosted by Ben Chodor, 3:00pm ET/12:00pm PT/2:00pm CT

LOS ANGELES, CA (Apr 3, 2015) – BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company that has developed a proprietary technology platform designed to greatly improve the rapidly growing $3 billion electrophysiology (EP) marketplace, announced today that Chief Executive Officer (CEO), President, and Director Gregory D. Cash will be interviewed live on iHeart Radio’s HealthTech Talk hosted by Ben Chodor and broadcasted nationwide on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM tomorrow, at 3:00pm ET. In this exclusive interview, Mr. Cash will discuss its product PURE EP™ System which EP is designed to improve outcomes of EP studies and cardiac catheter ablation, shorten procedure times and reduce recurrence rates. We encourage all shareholders, analysts, industry professionals and interested parties to tune in live. The details and link to iHeart Radio’s live worldwide stream are below.

Date: April 4, 2015
Start Time: 3:00pm ET | 12:00pm PT | 2:00pm CT (U.S.)
Network: iHeart Radio/ Clear Channel
Station: 640 WGST AM
Show: HealthTech Talk
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE

About BioSig Technologies, Inc.
BioSig Technologies, Inc. (BSGM) is a medical device company that has developed a proprietary technology platform designed to greatly improve the rapidly growing $3 billion electrophysiology (EP) marketplace. Led by a proven management team and a veteran, independent Board of Directors, Los Angeles-based BioSig is preparing to commercialize its PURE EP™ System.

PURE EP is designed to improve outcomes of EP studies and cardiac catheter ablation, shorten procedure times and reduce recurrence rates. It is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings and provide guidance in identifying ablation targets — areas of tissue to destroy that otherwise create a heart rhythm disturbance (arrhythmia). BioSig believes this information is not easily obtained, if at all, from any other EP equipment in the market today.

These ablation procedures treat cardiac arrhythmias, which are broadly defined as a set of conditions in which the electrical activity of the heart is irregular, or faster or slower than normal. This type of heart disease afflicts 14.4 million Americans, or one in 18. Two of the most prevalent and deadly types of arrhythmias today are Atrial Fibrillation (AF) and Ventricular Tachycardia (VT).

About CEO, President, and Director Gregory D. Cash
Greg Cash is an experienced executive and a seasoned industry veteran. He has over 30 years of business experience and has been chief executive officer of several companies, both public and privately held, as well as run global business units of larger companies.

Prior to joining BioSig, Mr. Cash was President and CEO of Argent International, a life sciences consulting firm. Previous positions include President and Chief Executive Officer of NeuroTherm, Inc., President and Chief Executive Officer, as well as a director of HeartSine Technologies, Inc., President, Vascular Therapy and New Businesses for Sorin Group based in Milan, Italy, President and Chief Executive Officer and a director of Vasomedical, Inc. a NASDAQ traded public company, Corporate Vice President, Datascope Corporation, and President of its subsidiary, InterVascular, Inc., President and Chief Operating Officer of Eminent Technology Partners and Chief Executive Office of its subsidiary, Eminent Research Systems, Vice President and General Manager, Vascular Therapies, for U.S. Surgical Corporation and spent five years with Boston Scientific Corporation, ultimately as Vice President, Cardiology Sales and Marketing, Europe. He began his career at Medtronic, Inc., where he served 14 years in increasingly senior sales and marketing positions.

Mr. Cash has lived and worked as an expatriate in London, England, Hong Kong, Paris, France and Milan, Italy and speaks French, German and Italian. He holds a B.A. in International Marketing and Business Administration from the College of St. Thomas in St. Paul, Minnesota.

About iHeart Radio/ Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About Health Tech Talk Live
Health Tech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s Health Tech Talk Live. Visit iHeart Radio’s HealthTech Talk Radio Show or visit www.HealthTechTalk.com.

If you’re interested in being a guest on Health Tech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

A 1800PublicRelations.com PR Event…

Interview Press / Media
Matthew Bird
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com
By HealthTech Talk Comments Off on CEO Gregory D. Cash of BioSig Technologies, Inc. to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM’s “HealthTech Talk” Read more...
16 Feb

Intelomed, Inc. CEO Jill Schiaparelli to Guest Host National Talk Radio Show at MD&M Conference in Philadelphia — iHeart Radio’s HealthTechTalk

MD&M Philadelphia Conference October 7th & 8th, Sponsored by UBM Canon MedTech World

WEXFORD, PA (Oct 6, 2015) – InteloMed, Inc., a leading developer of non-invasive cardiovascular monitoring systems, announced today that CEO Jill Schiaparelli will guest host a special edition of HealthTechTalk Live Radio Show at the UBM MedTech World Medical Design and Manufacturing (MD&M) conference in Philadelphia on October 7th and 8th, 2015.

Live on location from MD&M Philadelphia, the four-state region’s largest medtech event, HealthTechTalk Live will interview some of the most high-profile, innovative industry and academic leaders presenting at the conference.

Serving a broad community of medtech professionals, MD&M Philadelphia delves into the latest challenges and opportunities that are impacting the industry. A multi-track conference program explores design innovations, 3D printing, new materials, packaging design and more.

About UBM Canon
UBM Canon is the leading B-to-B event producer, publisher, and digital media company for the world’s $3 trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the advanced manufacturing market and leverage our proprietary 1.3 million name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. UBM Canon is part of UBM plc (UBM.L), a global provider of media and information services for professional B-to-B communities and markets.

About HealthTechTalk Live Radio Show
HealthTechTalk Live Show broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm every Saturday. Guest host Jill Schiaparelli interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s HealthTechTalk Live, http://www.healthtechtalk.com/

About InteloMed
InteloMed is redefining the standard of care in intelligent cardiovascular monitoring in hospitals and health care facilities through its non-invasive CVInsight™ Platform. The CVInsight™ Platform provides real-time insights on the stress level of the cardiovascular system to inform clinical decisions which, as part of a well-managed care plan, may lead to earlier detection of cardiovascular decline, earlier intervention, decreased hospitalization and improved patient outcomes. The CVInsight™ Platform has functionality in hospital and outpatient settings and has clinical applications in multiple areas including hemodialysis, heart failure, and the surgical continuum. InteloMed is headquartered in Wexford, PA. For more information, visit us at www.InteloMed.com.

Safe Harbor Statement
Certain statements in this release are “forward-looking” and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage qualified employees, the acceptance of new products by doctors and hospitals, changes in the regulatory environment and healthcare legislation, the need to keep pace with technological changes, our dependence on third party manufacturers to produce components of our technology platform on time and to our specifications, and the successful implementation of our commercial strategies.

A 1800PublicRelations.com PR Event…

PR / Media
Matthew Bird
President
1-800-PublicRelations, Inc.
646.401.4499
matt.bird@1800pr.com

By HealthTech Talk Comments Off on Intelomed, Inc. CEO Jill Schiaparelli to Guest Host National Talk Radio Show at MD&M Conference in Philadelphia — iHeart Radio’s HealthTechTalk Read more...
16 Feb

CEO Dr. Robin Smith of NeoStem to Discuss Agreement to Acquire California Stem Cell, Inc. Live Today on Clear Channel’s “The Traders Network Show”

Interview Airs at 2:30pm EDT / 1:30pm CDT / 11:30am PDT on the Traders Network Radio Show, Hosted by Michael Yorba

NEW YORK, NY–(Apr 15, 2014) – NeoStem, Inc. (NASDAQ: NBS) (“NeoStem”), a leader in the emerging cellular therapy industry, announced today that Chairman and CEO, Dr. Robin Smith, will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network Show. In this exclusive 2-segement interview, Dr. Smith will go over the strategic details of their contract to acquire California Stem Cell, Inc. (CSC) .

We encourage shareholders, analysts, industry professional and all interested parties to tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: Tue, April 15, 2014
Start Time: 11:30am PDT | 1:30pm CDT | 2:30pm EDT (U.S.)
Network: Clear Channel
Station: DFW 1190AM KFXR
Show: The Traders Network
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true

About Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.

About Michael Yorba
Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted The Traders Network Show broadcasted live daily on Clear Channel DFW 1190AM KFXR from 1pm – 3pm CT, Monday-Friday.

Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s The Traders Network Show.

About NeoStem, Inc.
NeoStem is a leader in the emerging cellular therapy industry, pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function. The business includes the development of novel proprietary cell therapy products as well as a revenue-generating contract development and manufacturing service business. This combination has created an organization with unique capabilities for cost effective in-house product development and immediate revenue and cash flow generation. www.neostem.com

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company’s business strategy, including with respect to the Company’s ability to consummate the CSC acquisition and the Company’s ability to develop and grow its business, the successful development of cellular therapies, including with respect to the Company’s research and development and clinical evaluation efforts in connection with the Company’s CD34 Cell Program and T Regulatory Cell Program and other cell therapies (including Melapuldencel-T if CSC is successfully acquired), the future of the regenerative medicine industry and the role of stem cells and cellular therapy in that industry and the performance and planned expansion of the Company’s contract development and manufacturing business. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the “Risk Factors” described in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 13, 2014 and in the Company’s periodic filings with the SEC. The Company’s further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.

A www.1800PublicRelations.com PR Event

Contact
Investor
LifeSci Advisors, LLC
Michael Rice
Founding Partner
Phone: +1-646-597-6979
Email: mrice@lifesciadvisors.com

Media
NeoStem, Inc.
Eric Powers
Manager of Communications and Marketing
Phone: +1-212-584-4173
Email: epowers@neostem.com

Press/Media
Matthew Bird, President
MUNCmedia Public Relations
+1 (917) 409-8211
matt.bird@muncmedia.com
www.muncmedia.com

By Traders Network Show Comments Off on CEO Dr. Robin Smith of NeoStem to Discuss Agreement to Acquire California Stem Cell, Inc. Live Today on Clear Channel’s “The Traders Network Show” Read more...
Visit Our BlogVisit Our BlogVisit Our Blog